ArticleBioengineering (Basel, Switzerland)2022

Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display.

Hiroaki Komuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.